Clinical Trials · NCT04159766
A Study With NLY01 in Subjects With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Neuraly, Inc.
- Enrollment
- 20
- Start date
- Oct 2019
- Locations
- 2 sites, Germany
- Primary endpoint
- Number of participants with Treatment Emergent Adverse Events